Amal Bassili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amal Bassili has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ibrahim Abubakar
Faculty of Population Health Sciences, University College London, London, UK
3 shared publications - Philippe Glaziou
World Health Organization
3 shared publications A Seita
2 shared publications- Ana Luiza Bierrenbach
Hospital Sírio-Libanês, Brazil
2 shared publications N. A. van Hest
2 shared publicationsA Al-Absi
1 shared publication
Latest Publications
- 1 April 2013
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 17 (4) , 456-461
Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen
BACKGROUND: The lack of applicable population-based methods to measure tuberculosis (TB) incidence rates directly at country level emphasises the global need to generate robust TB surveillance data to ascertain trends in disease burden and to assess the performance of TB control programmes in the context of the United Nations Millenium Development Goals and World Health Organization targets for TB control.OBJECTIVE: To estimate the incidence of TB cases (all forms) and sputum smear-positive disease, and the level of under-reporting of TB in Yemen in 2010.METHODS: Record-linkage and three-source capture-recapture analysis of data collected through active prospective longitudinal surveillance within the public and private non-National Tuberculosis Programme sector in twelve Yemeni governorates, selected by stratified cluster random sampling.RESULTS: For all TB cases, the estimated ratio of notified to incident cases and completeness of case ascertainment after record linkage, i.e., the ratio of detected to incident cases, was respectively 71% (95%CI 64–80) and 75% (95%CI 68–85). For sputum smear-positive TB cases, these ratios were respectively 67% (95%CI 58–75) and 76% (95%CI 66–84).CONCLUSION: We estimate that there were 13 082 (95%CI 11 610–14 513) TB cases in Yemen in 2010. Under-reporting of TB in Yemen is estimated at 29% (95%CI 20–36).
- 1 April 2013
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 17 (4) , 456-461
Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen
BACKGROUND: The lack of applicable population-based methods to measure tuberculosis (TB) incidence rates directly at country level emphasises the global need to generate robust TB surveillance data to ascertain trends in disease burden and to assess the performance of TB control programmes in the context of the United Nations Millenium Development Goals and World Health Organization targets for TB control.OBJECTIVE: To estimate the incidence of TB cases (all forms) and sputum smear-positive disease, and the level of under-reporting of TB in Yemen in 2010.METHODS: Record-linkage and three-source capture-recapture analysis of data collected through active prospective longitudinal surveillance within the public and private non-National Tuberculosis Programme sector in twelve Yemeni governorates, selected by stratified cluster random sampling.RESULTS: For all TB cases, the estimated ratio of notified to incident cases and completeness of case ascertainment after record linkage, i.e., the ratio of detected to incident cases, was respectively 71% (95%CI 64–80) and 75% (95%CI 68–85). For sputum smear-positive TB cases, these ratios were respectively 67% (95%CI 58–75) and 76% (95%CI 66–84).CONCLUSION: We estimate that there were 13 082 (95%CI 11 610–14 513) TB cases in Yemen in 2010. Under-reporting of TB in Yemen is estimated at 29% (95%CI 20–36).
- 1 April 2013
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 17 (4) , 462-467
Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq
BACKGROUND: The global target for tuberculosis (TB) control set by the Millennium Development Goals is a decrease in TB incidence by 2015. Direct measurement of country-level TB incidence using population-based methods is impractical, emphasising the need for well-performing surveillance systems and, where these are not available, accurate quantification of incidence and under-reporting of TB.OBJECTIVE: To estimate TB incidence and TB under-reporting in Iraq in 2011.METHODS: Prospective longitudinal surveillance was established among all eligible public and private non-National TB Programme (NTP) providers in a random sample of eight of the 18 Iraqi governorates from May to July 2011. Record linkage with the NTP and three-source capture-recapture analysis of data were then conducted using log-linear modelling.RESULTS: A total of 1985 TB cases were identified after record linkage. The NTP registered 1677 patients (observed completeness 84%). The estimated total number of TB cases was 2460 (95%CI 2381–2553), with identified TB cases representing 81% (95%CI 69–89) after adjusting for sampling design. The estimated ratio of notified to incident cases was 69% (95%CI 58–76).CONCLUSIONS: We estimate 14 500 TB cases in Iraq in 2011, of which 31% (95%CI 24–42) were unreported. TB surveillance needs to be strengthened to reduce under-reporting.
- 1 April 2013
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 17 (4) , 462-467
Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq
BACKGROUND: The global target for tuberculosis (TB) control set by the Millennium Development Goals is a decrease in TB incidence by 2015. Direct measurement of country-level TB incidence using population-based methods is impractical, emphasising the need for well-performing surveillance systems and, where these are not available, accurate quantification of incidence and under-reporting of TB.OBJECTIVE: To estimate TB incidence and TB under-reporting in Iraq in 2011.METHODS: Prospective longitudinal surveillance was established among all eligible public and private non-National TB Programme (NTP) providers in a random sample of eight of the 18 Iraqi governorates from May to July 2011. Record linkage with the NTP and three-source capture-recapture analysis of data were then conducted using log-linear modelling.RESULTS: A total of 1985 TB cases were identified after record linkage. The NTP registered 1677 patients (observed completeness 84%). The estimated total number of TB cases was 2460 (95%CI 2381–2553), with identified TB cases representing 81% (95%CI 69–89) after adjusting for sampling design. The estimated ratio of notified to incident cases was 69% (95%CI 58–76).CONCLUSIONS: We estimate 14 500 TB cases in Iraq in 2011, of which 31% (95%CI 24–42) were unreported. TB surveillance needs to be strengthened to reduce under-reporting.
- Open Access
- 14 June 2011
- Published by Springer Nature in Parasites & Vectors
- Vol. 4 (1) , 106
Zoonoses and marginalised infectious diseases of poverty: Where do we stand?
Despite growing awareness of the importance of controlling neglected tropical diseases as a contribution to poverty alleviation and achieving the Millennium Development Goals, there is a need to up-scale programmes to achieve wider public health benefits. This implementation deficit is attributable to several factors but one often overlooked is the specific difficulty in tackling diseases that involve both people and animals - the zoonoses. A Disease Reference Group on Zoonoses and Marginalised Infectious Diseases (DRG6) was convened by the Special Programme for Research and Training in Tropical Diseases (TDR), a programme executed by the World Health Organization and co-sponsored by UNICEF, UNDP, the World Bank and WHO. The key considerations included: (a) the general lack of reliable quantitative data on their public health burden; (b) the need to evaluate livestock production losses and their additional impacts on health and poverty; (c) the relevance of cross-sectoral issues essential to designing and implementing public health interventions for zoonotic diseases; and (d) identifying priority areas for research and interventions to harness resources most effectively. Beyond disease specific research issues, a set of common macro-priorities and interventions were identified which, if implemented through a more integrated approach by countries, would have a significant impact on human health of the most marginalised populations characteristically dependent on livestock.
- 14 June 2011
- Published by Springer Nature in Parasites & Vectors
- Vol. 4 (1) , 106
Open AccessZoonoses and marginalised infectious diseases of poverty: Where do we stand?
Despite growing awareness of the importance of controlling neglected tropical diseases as a contribution to poverty alleviation and achieving the Millennium Development Goals, there is a need to up-scale programmes to achieve wider public health benefits. This implementation deficit is attributable to several factors but one often overlooked is the specific difficulty in tackling diseases that involve both people and animals - the zoonoses. A Disease Reference Group on Zoonoses and Marginalised Infectious Diseases (DRG6) was convened by the Special Programme for Research and Training in Tropical Diseases (TDR), a programme executed by the World Health Organization and co-sponsored by UNICEF, UNDP, the World Bank and WHO. The key considerations included: (a) the general lack of reliable quantitative data on their public health burden; (b) the need to evaluate livestock production losses and their additional impacts on health and poverty; (c) the relevance of cross-sectoral issues essential to designing and implementing public health interventions for zoonotic diseases; and (d) identifying priority areas for research and interventions to harness resources most effectively. Beyond disease specific research issues, a set of common macro-priorities and interventions were identified which, if implemented through a more integrated approach by countries, would have a significant impact on human health of the most marginalised populations characteristically dependent on livestock.
- 1 April 2011
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 15 (4) , 556-561
Tuberculosis case finding in twenty-two countries of the Eastern Mediterranean Region [Notes from the field]
A hypothetical model has been developed to evaluate the efficiency of the case-finding process in 22 countries of the Eastern Mediterranean Region. The model is based on the patient's pathway to care in a stepwise approach from the community to the tuberculosis (TB) management units. Performance was measured using indicators for each of the components of the Stop TB strategy, and a scoring system was developed. The indicators significantly associated with TB case detection were then reported. This tool can assist countries in evaluating the efficiency of their surveillance system in detecting cases.
- 1 April 2011
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 15 (4) , 556-561
Tuberculosis case finding in twenty-two countries of the Eastern Mediterranean Region [Notes from the field]
A hypothetical model has been developed to evaluate the efficiency of the case-finding process in 22 countries of the Eastern Mediterranean Region. The model is based on the patient's pathway to care in a stepwise approach from the community to the tuberculosis (TB) management units. Performance was measured using indicators for each of the components of the Stop TB strategy, and a scoring system was developed. The indicators significantly associated with TB case detection were then reported. This tool can assist countries in evaluating the efficiency of their surveillance system in detecting cases.
- 1 June 2010
- Vol. 14 (6) , 727-32
Estimating tuberculosis case detection rate in resource-limited countries: a capture-recapture study in Egypt.
Most countries endemic and highly endemic for tuberculosis (TB) still do not have reliable TB surveillance systems. Indirect estimation of TB incidence is needed to monitor the performance of the National Tuberculosis Programme (NTP) in the context of the World Health Organization implementation and impact targets for TB control. To estimate the case detection rate (CDR) of all TB cases and sputum smear-positive TB cases in Egypt in 2007. Record linkage and three-source capture-recapture analysis of data collected through active prospective longitudinal surveillance within the public and private non-NTP sector in four Egyptian governorates selected by stratified cluster random sampling. For all TB cases, the estimated CDR of NTP surveillance and completeness of case ascertainment after record linkage was respectively 55% (95%CI 46-68) and 62% (95%CI 52-77). For sputum smear-positive TB cases, these proportions were respectively 66% (95%CI 55-75) and 72% (95%CI 60-82). This pilot study shows that representative sampling, prospective surveillance in the non-NTP sector, record linkage and capture-recapture analysis can improve CDR estimation. For global, standardised and reliable use, this methodology should be further developed. Until then, all resource-limited countries should strengthen their national surveillance systems in the context of the Stop TB strategy.
- 1 June 2010
- Vol. 14 (6) , 727-32
Estimating tuberculosis case detection rate in resource-limited countries: a capture-recapture study in Egypt.
Most countries endemic and highly endemic for tuberculosis (TB) still do not have reliable TB surveillance systems. Indirect estimation of TB incidence is needed to monitor the performance of the National Tuberculosis Programme (NTP) in the context of the World Health Organization implementation and impact targets for TB control. To estimate the case detection rate (CDR) of all TB cases and sputum smear-positive TB cases in Egypt in 2007. Record linkage and three-source capture-recapture analysis of data collected through active prospective longitudinal surveillance within the public and private non-NTP sector in four Egyptian governorates selected by stratified cluster random sampling. For all TB cases, the estimated CDR of NTP surveillance and completeness of case ascertainment after record linkage was respectively 55% (95%CI 46-68) and 62% (95%CI 52-77). For sputum smear-positive TB cases, these proportions were respectively 66% (95%CI 55-75) and 72% (95%CI 60-82). This pilot study shows that representative sampling, prospective surveillance in the non-NTP sector, record linkage and capture-recapture analysis can improve CDR estimation. For global, standardised and reliable use, this methodology should be further developed. Until then, all resource-limited countries should strengthen their national surveillance systems in the context of the Stop TB strategy.
- 1 September 2009
- Vol. 13 (9) , 1100-5
The decline of tuberculosis in Yemen: evaluation based on two nationwide tuberculin surveys.
Yemen. To review the epidemiological situation of tuberculosis (TB) in Yemen by conducting a tuberculin survey and by comparing the results obtained with those of a previous tuberculin survey from 1991. A nationwide tuberculin survey enrolling 31,276 schoolchildren aged between 7 and 12 years. Skin indurations were recorded for 28,499 schoolchildren, of whom 16,927 (59.4%) had no bacille Calmette-Guérin (BCG) scar. Analysis of the distribution of indurations was difficult as it did not show any bimodal pattern. Prevalence of infection and annual risk of tuberculosis infection (ARTI) were thus estimated using the mirror image and mixture methods, and not the cut-off point method. The two methods indicated similar results: respectively 0.45% and 0.51% for prevalence of infection, and 0.05% and 0.05% for ARTI. In comparison with the 1991 tuberculin survey, the average annual decline of ARTI was 9.0% by the mirror method and 5.5% by the mixture method. Yemen seems to have a low ARTI (0.05%), and TB infection seems to be declining considerably. Analysis of the survey results highlighted the limitations of tuberculin surveys in countries with comparable epidemiological situations.
- 1 September 2009
- Vol. 13 (9) , 1100-5
The decline of tuberculosis in Yemen: evaluation based on two nationwide tuberculin surveys.
Yemen. To review the epidemiological situation of tuberculosis (TB) in Yemen by conducting a tuberculin survey and by comparing the results obtained with those of a previous tuberculin survey from 1991. A nationwide tuberculin survey enrolling 31,276 schoolchildren aged between 7 and 12 years. Skin indurations were recorded for 28,499 schoolchildren, of whom 16,927 (59.4%) had no bacille Calmette-Guérin (BCG) scar. Analysis of the distribution of indurations was difficult as it did not show any bimodal pattern. Prevalence of infection and annual risk of tuberculosis infection (ARTI) were thus estimated using the mirror image and mixture methods, and not the cut-off point method. The two methods indicated similar results: respectively 0.45% and 0.51% for prevalence of infection, and 0.05% and 0.05% for ARTI. In comparison with the 1991 tuberculin survey, the average annual decline of ARTI was 9.0% by the mirror method and 5.5% by the mixture method. Yemen seems to have a low ARTI (0.05%), and TB infection seems to be declining considerably. Analysis of the survey results highlighted the limitations of tuberculin surveys in countries with comparable epidemiological situations.
- 1 January 2008
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 16 (1) , 23-35
Diagnostic and Treatment Delay in Tuberculosis in 7 Countries of the Eastern Mediterranean Region
Objectives A multicountry study was conducted during 2003-2004 to study the extent of delay in the diagnosis and treatment of patients with tuberculosis and its determinants. Methods The study was conducted in 7 countries of the Eastern Mediterranean Region. Five thousand fifty-three newly diagnosed, adult, smear-positive, pulmonary tuberculosis cases were enrolled in the study. They were interviewed according to a pretested and structured questionnaire about the various factors affecting timely treatment. Results and Conclusions The mean delay duration between the onset of symptoms until treatment with antituberculosis drugs ranged from 1.5 to 4 months in different countries. Patient delay-defined as the time interval between the onset of symptoms and first health-seeking behavior-ranged from a mean of 9.9 days in Pakistan to 69 days in Somalia, whereas system delay-defined as the time interval between the first health-seeking behavior and treatment-ranged from 5 days in Iraq to 90.7 days in Pakistan. The private sector was the first choice for more than two thirds of patients. The main determinants of delay were sociodemographic, economic, stigma, time to reach the health facility, seeking care at nonspecialized individuals, and visiting more than 1 health care encounter before diagnosis.
- 1 January 2008
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 16 (1) , 23-35
Diagnostic and Treatment Delay in Tuberculosis in 7 Countries of the Eastern Mediterranean Region
Objectives A multicountry study was conducted during 2003-2004 to study the extent of delay in the diagnosis and treatment of patients with tuberculosis and its determinants. Methods The study was conducted in 7 countries of the Eastern Mediterranean Region. Five thousand fifty-three newly diagnosed, adult, smear-positive, pulmonary tuberculosis cases were enrolled in the study. They were interviewed according to a pretested and structured questionnaire about the various factors affecting timely treatment. Results and Conclusions The mean delay duration between the onset of symptoms until treatment with antituberculosis drugs ranged from 1.5 to 4 months in different countries. Patient delay-defined as the time interval between the onset of symptoms and first health-seeking behavior-ranged from a mean of 9.9 days in Pakistan to 69 days in Somalia, whereas system delay-defined as the time interval between the first health-seeking behavior and treatment-ranged from 5 days in Iraq to 90.7 days in Pakistan. The private sector was the first choice for more than two thirds of patients. The main determinants of delay were sociodemographic, economic, stigma, time to reach the health facility, seeking care at nonspecialized individuals, and visiting more than 1 health care encounter before diagnosis.
- Open Access
- 29 June 2005
- Published by Springer Nature in Malaria Journal
- Vol. 4 (1) , 28
The quality of antimalarials available in Yemen
Background: Malaria has always been a major public health problem in Yemen. Several studies in developing countries have demonstrated ineffective and poor quality drugs including antimalarials. Therefore, quality assessment of antimalarial drugs is of crucial importance. This study aimed to assess the quality of antimalarials (chloroquine and sulfadoxine/pyrimethamine) available in Yemen and to determine whether the quality of these products was related to the level of the distribution chain at which the samples were collected or related to the manufacturers. Methods: Four samples from each antimalarial product were collected from each of the various levels of the distribution chain. One sample was kept with the research team. Two were tested at Sana'a and Aden Drug Quality Control Laboratories. The fourth was sent to the Centre for Quality Assurance of Medicines in Potchefstroom, South Africa, for analysis. Quality indicators measured were the content of the active ingredient and dissolution rate (for tablets only) in comparison to standard specifications for these products in the relevant pharmacopoeia. Results: The results identified several problems of sub-standard products within the drug distribution chain. They included high and low failures in ingredient content for chloroquine tablets and chloroquine syrup. There was some dissolution failure for chloroquine tablets, and high sulfadoxine/pyrimethamine tablets dissolution failures. Failures with the dissolution of the pyrimethamine were found at most of the collection points. No clear relationship neither between the quality products and the level of the distribution chain, nor between locally manufactured and imported products was observed. Conclusion: There are sub-standard antimalarial products circulating within the drug distribution chains in the country, which will have serious implications on the reduced therapeutic effectiveness and on the development of drug resistance. This appears to be due to non-compliance with Good Manufacturing Practice guidelines by manufacturers in the production of the antimalarials.
- 29 June 2005
- Published by Springer Nature in Malaria Journal
- Vol. 4 (1) , 28
Open AccessThe quality of antimalarials available in Yemen
Background: Malaria has always been a major public health problem in Yemen. Several studies in developing countries have demonstrated ineffective and poor quality drugs including antimalarials. Therefore, quality assessment of antimalarial drugs is of crucial importance. This study aimed to assess the quality of antimalarials (chloroquine and sulfadoxine/pyrimethamine) available in Yemen and to determine whether the quality of these products was related to the level of the distribution chain at which the samples were collected or related to the manufacturers. Methods: Four samples from each antimalarial product were collected from each of the various levels of the distribution chain. One sample was kept with the research team. Two were tested at Sana'a and Aden Drug Quality Control Laboratories. The fourth was sent to the Centre for Quality Assurance of Medicines in Potchefstroom, South Africa, for analysis. Quality indicators measured were the content of the active ingredient and dissolution rate (for tablets only) in comparison to standard specifications for these products in the relevant pharmacopoeia. Results: The results identified several problems of sub-standard products within the drug distribution chain. They included high and low failures in ingredient content for chloroquine tablets and chloroquine syrup. There was some dissolution failure for chloroquine tablets, and high sulfadoxine/pyrimethamine tablets dissolution failures. Failures with the dissolution of the pyrimethamine were found at most of the collection points. No clear relationship neither between the quality products and the level of the distribution chain, nor between locally manufactured and imported products was observed. Conclusion: There are sub-standard antimalarial products circulating within the drug distribution chains in the country, which will have serious implications on the reduced therapeutic effectiveness and on the development of drug resistance. This appears to be due to non-compliance with Good Manufacturing Practice guidelines by manufacturers in the production of the antimalarials.